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Abstract: Peroxisomal matrix proteins are transported into peroxisomes in a fully-folded state, but
whether multimeric proteins are imported as monomers or oligomers is still disputed. Here, we
used alanine:glyoxylate aminotransferase (AGT), a homodimeric pyridoxal 5′-phosphate (PLP)-
dependent enzyme, whose deficit causes primary hyperoxaluria type I (PH1), as a model protein
and compared the intracellular behavior and peroxisomal import of native dimeric and artificial
monomeric forms. Monomerization strongly reduces AGT intracellular stability and increases its
aggregation/degradation propensity. In addition, monomers are partly retained in the cytosol. To
assess possible differences in import kinetics, we engineered AGT to allow binding of a membrane-
permeable dye and followed its intracellular trafficking without interfering with its biochemical
properties. By fluorescence recovery after photobleaching, we measured the import rate in live cells.
Dimeric and monomeric AGT displayed a similar import rate, suggesting that the oligomeric state
per se does not influence import kinetics. However, when dimerization is compromised, monomers
are prone to misfolding events that can prevent peroxisomal import, a finding crucial to predicting
the consequences of PH1-causing mutations that destabilize the dimer. Treatment with pyridoxine
of cells expressing monomeric AGT promotes dimerization and folding, thus, demonstrating the
chaperone role of PLP. Our data support a model in which dimerization represents a potential key
checkpoint in the cytosol at the crossroad between misfolding and correct targeting, a possible general
mechanism for other oligomeric peroxisomal proteins.
Keywords: alanine:glyoxylate aminotransferase; pyridoxal phosphate; peroxisome; peroxisomal
import; dimerization; protein folding; fluorescence recovery after photobleaching
1. Introduction
About one third of all known proteins display an oligomeric structure, and most of
them are homodimeric enzymes [1]. Genetic saving and the gain of catalytic activity in
functionally-obligate dimers may account for the importance of dimerization, although
structural advantages, including higher thermodynamic stability and protection against
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misfolding and aggregation, likely play a major role [1,2]. Protein engineering techniques
to create artificial monomeric forms have been instrumental in understanding the impact of
dimerization on purified proteins [1], but whether these results can be extended to the cel-
lular environment in which the folding of the protein takes place has remained unexplored.
Several factors other than the intrinsic physico-chemical properties of the polypeptide chain
influence the energy landscape inside a cell, including not only the crowded environment,
the vectorial synthesis, and the presence of molecular chaperones, but also the possibility
to be imported in a subcellular organelle [3,4]. In the latter case, folding and targeting are
strictly intertwined processes. Indeed, proteins destined for the endoplasmic reticulum
or mitochondria must be extensively unfolded and acquire the tertiary and quaternary
structure once imported [5,6]. On the contrary, proteins destined for the nucleus or peroxi-
somes are imported in a fully-folded state and dimerization/oligomerization may occur
before or after the import [7]. While the monomer/dimer equilibrium has been shown to
influence the import and the functional properties of nuclear proteins [8–10], the impact of
the quaternary assembly on the import of peroxisomal proteins is still debated [7,11,12].
Peroxisomal matrix proteins are synthesized in the cytosol and post-translationally
imported by specific peroxisomal targeting sequences (PTS) [11]. Most proteins contain
a PTS type 1 (PTS1), a C-terminal tripeptide generally matching the consensus sequence
[S/A/C]-[K/R/H]-[L-M], which interacts with the cytosolic Pex5p receptor [7,11,13]. The
cargo-Pex5p complex forms the docking complex with Pex14p and Pex13p at the peroxiso-
mal membrane, where the cargo protein translocates via a poorly understood mechanism.
Some evidence supports an “oligomeric protein import model”, where homo- or hetero-
oligomerization occurs before import [14–19], while others are in favor of a “monomeric
import model”, where the binding of the Pex5p receptor blocks oligomerization until the
protein is released in the peroxisomal matrix [16,20–23]. However, these models have
been derived by using Green Fluorescent Protein-fusion proteins in intact cells, or in vitro
import assays based on isolated peroxisomes or semi-intact cellular systems that fail to
fully recapitulate the import kinetics of the native protein in the cellular environment.
To address this problem, we used, as model human peroxisomal alanine:glyoxylate
aminotransferase (AGT), a dimeric pyridoxal 5′-phosphate (PLP)-dependent enzyme whose
functional deficit causes primary hyperoxaluria type I (PH1) [24,25]. PH1 is a rare inherited
disease characterized by the progressive accumulation of calcium oxalate kidney stones
due to the oxidation of accumulating glyoxylate [26]. Human AGT is present as two
polymorphic forms, named major and minor allele, the latter characterized by two amino
acid changes, Pro11Leu and Ile340Met [27]. Although the Pro11Leu mutation generates a
putative N-terminal mitochondrial targeting sequence, protein mistargeting is prevented
unless PH1-linked mutations are present that destabilize the dimeric structure and enhance
interaction with molecular chaperones [28–31]. To assess the contribution of dimerization
to AGT folding and peroxisomal targeting, here, we compared the two native dimeric
forms of the protein encoded by the major (DMa) and the minor (DMi) allele, with the
corresponding artificial monomeric forms (MMa and MMi) obtained by the interfacial
mutations R118A/F238S/F240S. In a previous study, we characterized the MMi form, and
we reported that it is catalytically inactive but folded and able to bind PLP [32]. Here, we
found that forced monomerization increases protein aggregation and degradation but does
not prevent peroxisomal import. By resorting to a modified form of the protein able to
interact with a fluorescent probe in live cells, we determined the kinetics of peroxisomal
import and found that import depends on proper folding and not on quaternary structure
acquisition. These results illuminate on the cellular fate of AGT with potential implications
for the pathogenesis of PH1 and give useful insights into the general principles at the basis
of the import of other matrix peroxisomal proteins.
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2. Materials and Methods
2.1. Materials
PLP, pyridoxine (PN), L-alanine, sodium glyoxylate, NADH, rabbit muscle L-lactic
dehydrogenase (LDH), isopropyl-b-D-thiogalactopyranoside, MG132, chloroquine, and
cycloheximide, were obtained from Sigma-Aldrich (St. Louis, MO, USA). The FlAsH-
EDT2 probe was purchased from Thermo Scientific (Waltham, MA, USA). 8-anilino-1-
naphthalenesulfonic acid (ANS) was purchased from Molecular Probes (Eugene, OR, USA).
Ham’s F12 Glutamax medium without PN was purchased from Invitrogen (Carlsbad,
CA, USA). Rabbit polyclonal anti-AGT human, rabbit polyclonal anti-Pro11, and guinea
pig antiperoxisomal catalase antibodies were kindly provided by Prof. C.J. Danpure
(University College London). Anti-rabbit, anti-guinea pig and anti-mouse horseradish
peroxidase (HRP) antibodies were purchased from GE Healthcare (Chicago, IL, USA).
Oligonucleotides for site-directed mutagenesis were purchased from Eurofins Genomics
(Anzinger, Germany). All other chemicals were of the highest grade commercially available.
2.2. Site Directed Mutagenesis
The R118A, F238S, and F240S mutations were introduced on the available pAGT-Ma
and pAGT-Mi constructs for bacterial expression [33], as well as on the pcDNA3.1AGT-
Ma and pcDNA3.1AGT-Mi vectors for eukaryotic expression [34] using the Quick Change
Mutagenesis Kit (Stratagene, San Diego, CA, USA) and the primers previously reported [32].
The sequence encoding for the CCPGCC motif able to specifically bind the FlAsH-EDT2
dye was introduced at position 762 into the AGT coding sequence of the pAGT-Ma and
pcDNA3.1AGT-Ma vectors by insertional mutagenesis. The primers used were AGT-FlAsH1
(5′-CTTCTGGGGCTGTGACTGTTGTCCGGACCAGCCCAGGATG-3′ and its complement)
and AGT-FlAsH2 (5′-CTGTGACTGTTGTCCAGGCTGTTGTGACCAGCCCAGGATG-3′ and
its complement). Each construct was confirmed to be free of mutations by DNA sequencing.
The obtained pAGT-FlAsH-Ma and pcDNA3.1-FlAsH-Ma were then subjected to site-directed
mutagenesis to obtain constructs encoding the corresponding monomeric forms by introducing
the R118A, F238S, and F240S mutations. The amino acid sequence of each species under study
is reported in Figure S1.
2.3. Expression and Purification
Escherichia coli BL21(DE3) cells, transformed with vectors encoding DMa, DMi, MMa,
MMi, DMa-FlAsH, MMa-FlAsH, were grown in 4.5 L of Luria broth at 37
◦C to an ab-
sorbance at 600 nm of 0.4–0.6. Expression was induced with 0.1 mM isopropyl-b-D-
thiogalactopyranoside for 15 h at 30 ◦C. Cells were harvested and resuspended in 20 mM
sodium phosphate buffer, pH 7.4, containing 0.5 M NaCl, 20 mM imidazole, and 100 µM
PLP. β-mercaptoethanol (5 mM) was added to culture of proteins containing the FlAsH
motif. Lysozyme was added to a final concentration of 0.2 mg/mL, and the culture was
incubated for 15 min at room temperature. After a freeze–thaw, the lysate was centrifuged
at 30,000× g for 30 min at 4 ◦C. Then, the lysate was loaded on a HisPrep FF 16/10 equi-
librated with 20 mM sodium phosphate buffer, pH 7.4, containing 0.5 M NaCl, 40 mM
imidazole (plus 5 mM β-mercaptoethanol for proteins containing the FlAsH motif). A
linear gradient was then applied (0–100% in 200 mL) with the same buffer containing
500 mM imidazole. The proteins eluted between 200 and 300 mM imidazole. After addition
of 100 µM PLP, the protein solution was concentrated; imidazole and unbound coenzyme
were removed by extensive washing with 100 mM potassium phosphate buffer (KP), pH
7.4 (plus 5 mM β-mercaptoethanol for proteins containing the FlAsH motif), using Amicon
Ultra 10 concentrators (Amicon). The protein concentration of dimeric and monomeric
species was determined using extinction coefficients at 280 nm of 9.54 × 104 M−1 cm−1
and 4.61 × 104 M−1 cm−1, respectively. The PLP content of each enzymatic form was
determined by releasing the coenzyme in 0.1 M NaOH using the extinction coefficient of
6600 M−1 cm−1 at 388 nm. The apo forms of the FlAsH tagged proteins were prepared as
previously reported adding 5 mM β-mercaptoethanol in the buffers [35].
J. Pers. Med. 2021, 11, 273 4 of 19
2.4. Determination of the Enzyme-PLP Equilibrium Dissociation Constant (KD(PLP)) of MMa,
MMi, DMa-FlAsH, MMa-FlAsH
The KD(PLP) of DMa-FlAsH was calculated by measuring the intrinsic fluorescence
quenching (λexc 280 nm; λem 336 nm) of the apoenzyme (0.1 µM) incubated for 24 h
in the presence of PLP at a concentration range of 0.01–10 µM. The KD(PLP) of MMa and
MMa-FlAsH were determined by measuring the circular dichroism (CD) signal at 430 nm of
10 µM apoenzyme upon 24 h incubation in the presence of PLP at concentrations ranging
from 1 to 300 µM. Data were fitted to the following quadratic equation based on the
tight-binding hypothesis [36]:
Y = Ymax
[E]t + [PLP]t + KD(PLP) −
√
(





where [E]t and [PLP]t represent total concentrations of the mutant and PLP, respectively;
Y refers to either intrinsic fluorescence quenching or 430 nm dichroic signal changes at
each PLP concentration; and Ymax refers to the aforementioned changes when all enzyme
molecules are complexed with the coenzyme.
2.5. Kinetic Parameters
The kinetic parameters for the overall transamination reaction of the alanine/glyoxylate
pair were determined at 0.1 µM enzyme concentration in the presence of saturating PLP
concentrations by varying the substrate concentration at a fixed saturating cosubstrate
concentration in KP 0.1 M, pH 7.4, at 25 ◦C. The specific transaminase activity of cellular
clones was determined by incubating each cellular lysate with L-alanine and glyoxylate
at saturating concentrations in KP 0.1 M, pH 7.4, at 25 ◦C. In both cases, the reaction was
stopped by adding trichloroacetic acid 10% (v/v), and pyruvate production was measured
using the spectrophotometric assay coupled with LDH, as previously reported [37].
2.6. Size Exclusion Chromatography
Size exclusion chromatography analyses were performed on an Akta fast protein
liquid chromatography system (GE Healthcare, Chicago, IL, USA) using a Superdex 200
10/300 GL column at room temperature. The mobile phase used for MMa, MMi, DMa-
FlAsH, and MMa-FlAsH was KP 0.1 M, pH 7.4. Detection was set at 280 nm, the flow rate
at 0.5 mL/min and the injection volume was 100 µL. Each sample was dissolved in KP 0.1
M, pH 7.4, at different concentrations and incubated overnight at 25 ◦C (a sufficient time
to reach equilibrium between monomer and dimer). Monomer and dimer concentration
were determined by integrating the area under the curve and expressed as percent of
total area of all protein-related peaks, as previously described [32], using the Unicorn 5.01
(GE Healthcare) software. According to Manning et al. [38], the KD(dim-mon) value was











where %D is the percentage of dimer to total enzyme and [E] represents the total enzyme
concentration in dimer equivalents. A plot of log[%D/0.04(100-%D)2] with respect to log[E]
yields a straight line of slope 1. When log[%D/0.04(%D-100)2] = 1, KD(dim-mon) = [E].
2.7. Spectroscopic Measurements
Absorption measurements were made using a Jasco V-550 (Jasco-Europe, Cremella
(LC), Italy) spectrophotometer with 1-cm path-length quartz cuvettes at a protein con-
centration of 1–10 µM in KP 0.1 M, pH 7.4. Near UV-visible and far-UV CD spectra and
thermal denaturation curves were recorded on a Jasco J-710 spectropolarimeter (Jasco-
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Europe, Cremella (LC), Italy) equipped with a Peltier temperature-controlled compartment
by using 1 cm and 1 mm path-length cells, respectively. The enzyme concentration was
0.1–15 µM. Routinely, three spectra were recorded at a scan speed of 50 nm/min−1 with a
bandwidth of 2 nm and averaged automatically.
2.8. Differential Scanning Calorimetry
Experiments were performed in a capillary VP-DSC microcalorimeter with a cell
volume of 135 µL. Buffer used was Na-Hepes 20 mM; NaCl 200 mM, pH 7.4; and 0.2 mM
β-mercaptoethanol. Proteins in the holo-form were prepared in this buffer with 0.1 mM
PLP. Scans were performed in a 2–110 ◦C range at scan rates from 1.5–4 ◦C/min. Data were
corrected for the instrumental response time and analyzed using a two-state irreversible
model with first order kinetics [39]. The validity of the model was confirmed by comparing
data at different scan rates and protein concentrations as already described [39].
2.9. Isothermal Titration Calorimetry
Experiments were performed in a VP-ITC200 microcalorimeter with a cell volume of
205 µL. Experiments were carried out in Na-Hepes 20 mM, NaCl 200 mM, or KP 0.1 M at
pH 7.4 in the presence of 0.2 mM β-mercaptoethanol. The PTS1 binding domain of Pex5p
(Pex5p-pbd) was placed in the titration syringe at 290 µM, and AGT variants at 9–11 µM (in
monomer) in the sample cell (occasionally, the cell was filled with buffer in blank titrations).
Titrations were performed by an initial injection of 0.5 µL, followed by fifteen injections of
2.5 µL spaced 200 s. Titrations were carried out at 10 ◦C in the high feedback mode. Data
were analyzed using the software provided by the manufacturer, using a single-type of
sites binding model and fixing the stoichiometry to 1 due to low affinities.
2.10. Cell Culture, Transfection, and Lysis
Chinese hamster ovary cells stably expressing glycolate oxidase (CHO-GO) were
cultured at 37 ◦C under O2/CO2 (19:1) atmosphere in Low-B6 medium consisting of a
custom-made B6 free Ham’s F12 medium (Invitrogen, Carlsbad, CA, USA) supplemented
with fetal bovine serum (10%, v/v), penicillin (100 units/mL), streptomycin (100 µg/mL),
and zeocin (0.4 µg/mL). PN concentration in the Low-B6 medium was <<0.3 µM [40].
CHO-GO cells were transfected using the Turbofect™ Transfection Reagent (Fermentas,
Waltham, MA, USA) according to the manufacturer’s instructions. In order to obtain stable
clones, 24 h after transfection, the selection agent geneticin (G418, 1 mg/mL) was added to
the medium of transfected cells. Cells were then kept in culture for at least two weeks to
eliminate all the cells not expressing AGT. The homogeneous and stable expression of AGT
of each clone was checked by Western blot and immunofluorescence microscopy.
Cell pellets were lysed in phosphate buffered saline (PBS), pH 7.2, plus protease
inhibitor cocktail Complete Mini (Roche, Basilea, Switzerland), by five freeze/thaw cycles
followed by treatment with DNAse (1 unit) at RT for 45 min. The latter procedure was able
to disrupt organelles completely, thus, allowing peroxisomal and mitochondrial AGT to
be extracted, as previously shown by our group and others [34,41]. The whole cell extract
was separated by centrifugation (12,900× g, 10 min, 4 ◦C) to obtain the soluble fraction.
The pellets were then resuspended in an equal volume of denaturing gel loading buffer
to obtain the insoluble fraction. The protein concentration of the soluble cell lysate was
determined in quadruplicate by using the Bradford protein assay.
2.11. Western-Blot and Pulse-Chase Experiments
5–10 micrograms of soluble and/or insoluble cell lysate were loaded per lane on
a 10% SDS-PAGE gel along with the Precision plus protein KaleidoscopeTM (Bio-Rad,
Hercules, CA, USA) or the SharpMass VI (Euroclone, Pero (MI), Italy) molecular mass
markers. Proteins were then transferred on a nitrocellulose membrane using the iBlot
device (Invitrogen), followed by blocking on 5% milk (w/v) in TBST buffer (10 mM Tris-
HCl, pH 7.2; 0.1 M NaCl; and 1% Tween20) at 37 ◦C for one hour. For AGT detection,
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the membrane was incubated with the polyclonal rabbit anti-AGT primary antibody
(dilution 1:6000), the anti-Leu11 primary antibody (dilution 1:2000), or the anti-Pro11
antibody (dilution 1:2000) for 15 h at 4 ◦C. Peroxidase-conjugated anti-rabbit IgG was
used as secondary antibody (dilution 1:10,000). Indicated cells were treated with MG132
(10 µM) or chloroquine (50 µM) for 24 h before the immunoblot analysis. Band detection
was performed by using the enhanced chemi-luminescence (ECL) substrate reagent using
a Chemidoc system (Biorad). Band volume (intensity/mm2) was quantified using the
software QuantityOne. To control for protein loading, protein quantification in the cellular
lysates was performed in quadruplicate for each sample, blotted membranes were inspected
by staining with Ponceau solution (Sigma-Aldrich, St. Louis, MO, USA), and a non-
specific band responsive to the anti-AGT antibody also present in the negative control
(non-transfected cells), was analyzed in each blot. All the blots presented in this work were
consistent with a similar protein loading among each sample.
Cross-linking was performed using bis-N-succinimidyl-(pentaethylene glycol) ester
(BS(PEG)5) (Pierce, Waltham, MA, USA). Twenty-five micrograms of the whole cellu-
lar lysate were cross-linked with BS(PEG)5 at 1 mM or 10 mM final concentrations and
quenched in 0.5 M Tris-HCl, pH 7.5, after 30 min. Ten micrograms of each sample were
analyzed by Western blotting.
In order to determine the half-life of each species, cells were treated with cyclo-
heximide, a known inhibitor of ribosomal protein synthesis [42]. Briefly, cycloheximide
(10 µg/mL) was added to the medium of cells at 70–80% confluence. At different times (0,
8, 12, and 24 h) cells were harvested, lysed, and AGT levels were measured by Western
blot, as described above.
2.12. Immunofluorescence Microscopy (IFM)
AGT subcellular localization was investigated by confocal microscopy experiments
performed both in fixed and live cells. In the first case, approximately 3 × 105 cells were
seeded into each well of a 24-well plate containing a 13-mm glass coverslip. Twenty-four
hours later, cells were fixed in 4% (w/v) paraformaldehyde, permeabilized with 0.3% Triton
X-100 in PBS, and blocked in 3% BSA in PBS. For the immunolabelling, rabbit polyclonal
anti-human AGT and anti-peroxisomal catalase from guinea pig [43] were used as pri-
mary antibodies, and Alexa Fluor conjugated antibodies (AF488 and AF555, from Life
technologies, Carlsbad, CA, USA) were used as secondary antibodies. Nuclei were stained
with DAPI (Molecular Probes, Eugene, OR, USA). The coverslips were then mounted
over slides in AF1 medium (Dako, Agilent, Santa Clara, CA, USA). For live cell imaging
experiments, 3 × 105 CHO-GO-DMa-FlAsH or CHO-GO-MMa-FlAsH cells were seeded
into each well of a 4-well chamber slide with a 13-mm glass bottom. Twenty-four hours
later, the culture media was removed, and each well was washed with HBSS (Hank’s
balanced salt solution with Ca2+ and Mg2+ without phenol red Gibco®). Then, the staining
solution made of Hoechst 5 µg/mL (nuclear staining, ThermoFisher, Waltham, MA, USA)
and FlAsH 1 µM in HBSS was added to each well and incubated for 15–30′ in the cell
incubator. After the removal of the staining solution, each well underwent three washing
steps in BAL buffer (0.25 mM, ThermoFisher, Waltham, MA, USA). Finally, 250 µL of HBSS
was added to each well before confocal imaging. Images were captured using a confocal
laser-scanning fluorescence microscope Leica SP5 (Molecular Probes, Leica Microsystem,
Wetzlar, Germany) at 63× magnification. Three-dimensional stack images of cells express-
ing monomeric forms were deconvolved using Huygens Professional software package
(version 19.04, Scientific Volume Imaging B.V. Hilversum The Netherlands, http://svi.nl
(access on 1 January 2021)). A theoretical point spread function (PSF) was used, choosing
the classical maximum likelihood estimation (CMLE) algorithm. Deconvolved images
were visualized by twin slicer mode of Huygens, which provides information related to
the fluorescence signal and its position inside the cell to show the co-localization of green
(AGT) and red (peroxisomes) signals. For qualitative analysis, the ImageJ software was
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used (http://rsb.info.nih.gov/ij/, 1997–2008, (access on 1 January 2021)). Figure cropping
and labelling were performed using Adobe Photoshop.
2.13. Fluorescence Recovery after Photo-Bleaching (FRAP)
Fluorescence recovery after photo-bleaching (FRAP) was used to investigate the
peroxisomal import kinetics in CHO-GO cells stably expressing DMa-FlAsH and MMa-
FlAsH. Cells were plated in 8-well slide ibidi chambers (Ibidi 80826) in complete media.
After 48 h, cells were washed in HBSS and incubated in 1 µm FlAsH labelling solution for
20 min at 37 ◦C with 5% CO2. After washing three times in BAL buffer, cells were restored to
complete media and directly observed using a Zeiss LSM780 confocal microscope enclosed
in a Solent chamber kept at 37 ◦C with a supply of 5% CO2. For the FRAP studies, FlAsH
was imaged and bleached using a Plan-Apochromat 63×/1.4 Oil objective with 488 nm
laser excitation and emission collected between 500–648 nm. Regions of interest (ROIs)
of a fixed dimension enclosing a peroxisome were defined, and pre- and post-bleach
images were collected as part of a time series to a maximum of 350 s. Untransfected cells
were analyzed as negative control, but their autofluorescent signals were undetectable
as compared with the fluorescence signal of transfected samples. One peroxisome was
bleached per cell, and at least 20 cells were bleached for each experiment. Data were taken
from multiple cells and days for each experiment type. About half the FRAP sets were
not analyzed due to organelle movement or loss of focus, but at least 10 were included
in computation of each of the recovery time values. The FRAP curves were normalized
to 100% for the mean pre-bleached signal. Analysis of the dimer and monomer major
alleles (DMa-FlAsH, MMa-FlAsH) was usually performed using SigmaPlot v14 and a simple
recovery time constant was obtained by fitting the data with a single exponential rise to
the final intensity:








where A(t) is the bleach signal at times t, a is the pre-exponential value, a0 is the eventual
recovery level, and T 1
2
is the time constant of the bleach recovery. Analysis of some
traces of MMa-FlAsH was more complicated due to fading and/or movement of the
peroxisomes. Analysis was therefore based on single particle fluorescence analysis, and
recovery profiles of either intensity or total signal were fitted by the same exponential rise
described by Equation (3), but with the final signal a0 replaced by a fading term modelled
as an exponential decay:














where T0 is the time constant of the background fading, using iterative non-linear regression.
Repeat bleaching experiments were also conducted on DMa-FlAsH and MMa-FlAsH using
the same conditions as above but using a larger bleach region encompassing more than
one cell. Here, the bleaching was repeated after every second image and with an interval
of 20 s between images to allow for recovery.
2.14. Statistical Analysis
Experiments were performed at least in triplicate. Statistical analyses were performed
using Origin® 8 (Origin Lab) or GraphPad Prism Version 6.0 (GraphPad software, San
Diego, CA, USA).
3. Results
3.1. Biochemical Features of Purified Monomeric and Dimeric AGT
A purified monomeric form of AGT obtained through the interfacial mutations
R118A/F238S/F240S on the background of the minor allele (MMi) has been already charac-
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terized by our group [32]. Here, we also constructed a monomeric form on the background
of the major allele (MMa) by inserting the same interfacial mutations. Size-exclusion chro-
matography experiments confirmed that the inserted mutations remarkably increased
the KD(dim-mon) values of both DMa and DMi in both the apo- and the holo-form (Table 1).
It should be observed that the effect of the mutations on dimer stability was higher for
DMi than for DMa, thus suggesting that they could somehow synergize with the minor
allele polymorphic changes. As a necessary premise for the studies in a cellular system,
we compared the biochemical properties of the purified dimeric and monomeric forms
of AGT. MMa and MMi were folded in solution, as shown by their intrinsic fluorescence
emission and far-UV dichroic spectra (Figure S2a and inset) reporting on their tertiary
and secondary structure, respectively. As expected, both monomers were catalytically
inactive ([44] and Figure S2b), in line with AGT being a functionally-obligate dimer. In
addition, they differed from the corresponding dimeric forms for (i) the higher content of
hydrophobic surfaces, indicated by their increased fluorescence emission in the presence
of the probe ANS (Figure S2c) that binds exposed hydrophobic patches, as previously
observed under native and denatured conditions [32,45] and (ii) the lower PLP-binding
affinity (Table 1) due to the fact that the coenzyme is held in place by residues coming
from both subunits [44]. MMa and MMi displayed a sigmoidal thermal-unfolding curve
(Figure S2d) but showed a reduced melting temperature as compared with the correspond-
ing dimeric species, in line with spectroscopic data indicating that monomeric AGT is
folded but dimerization strongly influences protein stability. Finally, each apoenzyme
showed a reduced melting temperature as compared with the corresponding holoenzyme,
confirming the structural role of PLP (Table 1).
Table 1. Parameters for quaternary structure, pyridoxal 5′-phosphate (PLP) binding and thermal denaturation of ala-
nine:glyoxylate aminotransferase (AGT) enzymes. Experiments were performed in KP 0.1 M, pH 7.4. Values of KD(PLP) and
Tm of MMa and MMi were determined at a protein concentration in which the monomeric form was >90%. Tm values were
obtained by monitoring the loss of circular dichroism (CD) signal at 222 nm. Data on the holo-forms were determined in the
















MMa 4.1 ± 0.3 1.5 ± 0.3 3.2 ± 0.6 54.6 ± 0.3 54.9 ± 0.3




MMi 80 ± 1 9.4 ± 0.5 4.4 ± 0.5 47.3 ± 0.3 50.1 ± 0.1
a The two Tm values of the DMa and DMi species have been attributed to the unfolding of the large and small domains of AGT (see ref. [46]).
3.2. Expression of Monomeric and Dimeric AGT in Mammalian Cells
To assess how dimerization affects the intracellular fitness of AGT, we expressed
DMa, MMa, DMi, and MMi in a cellular system by using a model of PH1 made up of
CHO-GO cells [43], cultured in a low-Vitamin B6 medium to better mimic a physiological
extracellular environment [40,47]. As expected, cells expressing DMa and DMi displayed
AGT specific activity values of 150 ± 5 and 114 ± 8 nmol/min/mg protein, respectively,
while no transaminase activity could be detected in lysates of cells expressing MMa and
MMi, in line with the results on purified proteins. Cross-linking experiments (Figure S3a)
confirmed that AGT was present as a dimer in cells expressing DMa and DMi. Under the
same conditions, MMa was mostly present in a 37 kDa monomeric form, with faint bands
at the level of the dimer and at higher molecular weight, while only a faint band at an
apparent molecular weight < 37 KDa was detected in cells expressing MMi. To further
investigate the cellular fate of monomeric AGT, protein levels were evaluated in the soluble
and insoluble fractions of cells expressing DMa, MMa, DMi, or MMi (Figure 1a,b). The total
amount of MMa and MMi was reduced to 43% and 19% of DMa and DMi, respectively,
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and more than 75% of the protein was present in the insoluble fraction. In addition, a
band at approximately 35 kDa was present in the lysate of cells expressing DMi and MMi,
which represents a truncated form obtained upon N-terminal cleavage, as confirmed by
using antibodies specifically targeting the N-terminus (Figure 1c). Addition of pyridoxine
(PN), a precursor of PLP used in clinics and as a food additive [48], increased the levels
of soluble MMa (Figure 1a,b) and led to the appearance of dimeric species in cross-linking
experiments (Figure S3b). In order to increase the population of dimeric species in cells
expressing MMa in the presence of PN, we treated with a 50× molar excess of cross-
linker due to the very low efficiency of the cross-linking process already observed in the
same cellular system [49]. Under the latter conditions, the band of the monomer in the
absence of PN was no more visible because the equilibrium was shifted toward aggregates.
Nevertheless, these data are in line with the results obtained with the purified protein,
indicating that PLP binding promotes dimerization [32] and that holoAGT is less prone to
aggregation [50]. No effects were observed when the same treatment was performed in cells
expressing MMi. Since MMi displays a KD(dim-mon) value higher than MMa (Table 1), it can
be hypothesized that it is unable to dimerize even in the presence of the high intracellular
PLP concentrations resulting from PN treatment. Therefore, the artificial monomeric forms
of AGT tend to undergo aggregation and proteolytic degradation. The aggregation of
MMa can be counteracted by the administration of exogenous coenzyme that induces
dimerization. In the case of MMi, since the full-length form is present at very low levels
and no effect is observed in the presence of PN, we considered only DMa and MMa for the
subsequent experiments.
We first compared the intracellular stability of MMa with that of DMa by a cyclohex-
imide chase assay (Figure 2a). While DMa levels were stable up to 24 h, we observed a
time-dependent decrease of the MMa levels. By fitting the densitometric data as a function
of time, we calculated the half-life of the protein, which was found to be 9.1 ± 0.9 h.
To investigate the mechanisms underlying the reduced half-life of MMa, we treated cells
with (i) MG132, a well-recognized inhibitor of the ubiquitin-proteasome system (UPS),
or (ii) chloroquine, a molecule that prevents lysosomal degradation and could report on
possible microautophagy or pexophagy events [48,49]. While treatment with chloroquine
caused no effect, MG132 reduced the soluble levels of monomeric AGT while promoting
an accumulation of the protein in the insoluble fraction (Figure S4 and Figure 2b). This
result is consistent with the hypothesis that UPS could be involved in the degradation of
partly-folded monomeric intermediates that accumulate in the cytosol and self-aggregate
upon proteosomal inhibition.
Altogether, our results indicate that, when expressed in eukaryotic cells, MMa and MMi
do not display any transaminase activity and are expressed at reduced levels as compared
to DMa and DMi. Two factors contribute to the latter effect: (i) the increased tendency
to aggregation and (ii) the higher susceptibility to undergo proteolytic cleavage at the
N-terminus, which reduces the intracellular half-life of the protein by possibly stimulating
degradation by the UPS. All the effects attributed to monomerization are potentiated by
the presence of the minor allele polymorphic mutations but reduced by the addition of
exogenous coenzyme.
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Figure 1. Analysis of AGT protein levels in the absence or presence of pyroxidine (PN). (a) Chinese hamster ovary cells
stably expressing glycolate oxidase (CHO-GO) untransfected (Ctrl) or expressing the indicated AGT species, treated or not
with PN (10 µM) for 7 days, were lysed, and 5 (DMa/MMa) or 10 (DMi/MMi) µg of the soluble and insoluble (as indicated)
fractions were analyzed by Western blot with an anti-AGT antibody from rabbit. (b) Immunoblot band volumes are
represented as histograms and expressed as percentage of the protein present in the soluble (black) and insoluble (grey)
fractions of the cell lysate relative to DMa. Data are expressed as mean ± SEM (n = 4). *, p < 0.05 (c) The soluble fraction of
each lysate was analyzed by Western blot using antibodies that specifically recognize the AGT N-terminus (antiPro11 for
DMa and MMa; antiLeu11 for DMi and MMi). The arrow in panels (a,c) indicates the band relative to AGT.
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Figure 2. Intracellular stability of monomeric and dimeric AGT. (a) Measurement of the half-life of DMa and MMa by a
cycloheximide chase assay. CHO-GO cells expressing either DMa or MMa were grown in the presence of cycloheximide
(10 µg/mL); at different times cells were harvested and lysed. Five micrograms of cell lysates were analyzed by Western
blot with an anti-AGT antibody from rabbit. The arrow indicates the band relative to AGT (b) Effect of the treatment with
MG132 on the AGT expression levels of CHO-GO expressing MMa. CHO-GO cells expressing MMa were treated for 24 h
with 10 µM MG132 and 10 µg of lysate were analyzed by Western blot for the amount of AGT in the soluble (Sol) and
insoluble (Ins) fraction using an antibody against AGT from rabbit. Ctrl represents the positive control of CHO-GO cells
expressing DMa. Images shown are representative of at least three independent experiments.
3.3. Subcellular Localization of Monomeric and Dimeric AGT
DMa showed a clear peroxisomal localization in CHO-GO cells, as revealed by im-
munofluorescence microscopy (Figure 3a). Intriguingly, we also detected the presence
of peroxisomal AGT in cells expressing MMa, indicating that monomers are able to be
imported in the peroxisomal matrix, as confirmed by the image deconvolution analysis and
RGB profiles shown in Figure 3b, where the AGT signal colocalizes with that of catalase.
However, part of the protein showed a cytosolic localization, indicating that the oligomeric
state can influence the subcellular localization of AGT by reducing the efficiency of the per-
oxisomal import. However, since immunofluorescence microscopy (IFM) experiments are
performed in fixed cells, they give a snapshot of the steady-state intracellular localization
of the protein without any information on the import kinetics.
We, therefore, resorted to live-cell confocal microscopy and used the technology based
on the fluorescent dye FlAsH-EDT2 to label AGT without any impact on the structure
and/or the intracellular behavior of the protein. FlAsH-EDT2 is a membrane-permeable
dye that emits fluorescence upon specific binding to the CCXXCC motif [51]. We engineered
AGT by inserting the CCPGCC sequence between Asp244 and Asp245, an exposed region
whose alteration is not predicted to affect the enzyme functional and structural properties,
as previously reported by our group [52]. When compared to the corresponding unmod-
ified form, recombinant purified DMa-FlAsH and MMa-FlAsH displayed similar kinetic
and coenzyme binding properties (Table S1), thus indicating that the inserted CCPGCC
sequence did not alter the overall structural and functional properties of the enzyme. As
expected, the insertion of the R118A/F238S/F240S interfacial mutations on DMa-FlAsH
completely abolished catalytic activity and reduced coenzyme binding affinity [32]. In
addition, DMa-FlAsH displayed thermal stability parameters analogous to those shown
in Table 1 and to those previously reported for DMa [39], with a similar denaturation
enthalpy and only a 4 ◦C reduction of the Tm value (Table S2). Since it is known that the
use of reducing agents does not affect AGT thermal stability [39], these data indicate that
the FlAsH-EDT2 recognition sequence has little effect on AGT stability and denaturation
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mechanism. As for MMa-FlAsH, the finding that it displays a strongly reduced thermal
stability is in line with previous data on monomeric AGT [32] and those shown in Table 1,
indicating a Tm value reduced by 22–24
◦C with respect to the corresponding dimeric form.
We also tested the interaction of the two forms with the Pex5p carrier and found that the
insertion of the FlAsH recognition sequence did not prevent binding (Table S3, Figure S5),
and that the binding parameters of the monomeric and dimeric form are similar, thus,
supporting the idea that dimerization is not critical for binding. Finally, we verified that
the FlAsH-EDT2 dye emits fluorescence at 533 nm (excitation at 508 nm) upon binding to
DMa-FlAsH, and that the signal is stable for at least 5 min. This is in line with the high
affinity and specificity, as well as with the stability of binding previously observed [53].
 
Figure 3. Subcellular distribution of monomeric and dimeric AGT. (a) CHO-GO cells expressing
either DMa or MMa were fixed and stained with antibodies against AGT (green) and peroxisomal
protein catalase (red). Nuclei were stained with Dapi (blue). Merged and single channel images come
from a single z-plane. Scale bar: 10 µm. (b) Deconvolution of IFM images for MMa shown in panel
(a) along with the corresponding RGB profiles.
When expressed in CHO-GO cells, MMa and MMa-FlAsH displayed an analogous
quaternary assembly, although the insertion of the CCPGCC sequence caused a reduction
of the AGT levels (Figure S6). It can be hypothesized that the inserted sequence increases
the flexibility of the surface loop 251–266 and makes the protein more susceptible to
degradation inside the cell. In agreement with the data obtained in fixed cells expressing
the untagged forms, in live cell imaging experiments on cells expressing DMa-FlAsH,
the FlAsH-EDT2 dye generated a pattern consistent with the peroxisomal localization of
dimeric AGT, while in cells expressing MMa-FlAsH, the strong fluorescence associated with
peroxisomes was accompanied by a diffuse fluorescent signal in the cell cytosol, confirming
the partial cytosolic localization of the artificial monomeric forms (Figure S6).
Overall, these data validate the use of FlAsH-tagged forms as models for live cell
imaging experiments.
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3.4. Peroxisomal Import Kinetics of Monomeric and Dimeric AGT
We measured the peroxisomal import rate of DMa-FlAsH and MMa-FlAsH by studying
the recovery of the fluorescence after photo-bleaching a whole peroxisome. Considering
that no free dye was present during the experiment, that the dye emitted fluorescence
only when it was bound to the CCPGCC motif, and that the signal was stable during the
timescale of the FRAP experiment, we can be confident that the recovery of fluorescence is
associated with the presence of new AGT-FlAsH molecules, thus, informing on the kinetics
of import (Movies S1 and S2). As a control, we first analyzed whether the fluorescence
outside of the bleached area dropped after repeated bleaching, to demonstrate that the
system is able to return to equilibrium. As shown in Figure S7 and Movies S3 and S4,
we repeatedly bleached a large area over more than one cell and could show that the
regions of interest (ROIs) in the bleached cells but outside of the bleach region also lost
fluorescence, not through dark state nor through acquisitional bleaching. Thus, equilibrium
was restored as the bleached ROI proteins were able to exit and equilibrate within the
cell, a finding that further corroborates that the fluorescence recovery after bleaching is
due to an import of particles into peroxisomes and not to aggregates. In preliminary
experiments, we also found that, during image acquisition, there was a progressive slight
loss of fluorescent signal. Thus, in all FRAP experiments, we registered the fluorescence of
two regions: the bleached ROI corresponding to a peroxisome, to determine the kinetics of
import, and a non-bleached control ROI (Figure 4). The latter is fundamental to understand
whether the recovery of fluorescence in the bleached region has plateaued. The signal
corresponding to the peroxisome showed a rapid recovery after bleaching, which stabilized
in less than 30 s once equilibrium had been reached. From these data, we could estimate
that DMa-FlAsH and MMa-FlAsH display identical time constants (2.5 ± 0.3 s vs. 2.5 ± 0.4 s,
respectively). This would indicate that the oligomeric state of the protein does not influence
import kinetics.
 
Figure 4. Fluorescence recovery after photo-bleaching (FRAP) curves. Graphs showing the recovery
of fluorescence as a function of time of (a) MMa, (b) DMa. Each panel shows a Scheme 4 (panel (a)) or
3 (panel (b)), and a control area from a non-bleached region of interest showing acquisitional bleach
(red circles). The intensity axis has been normalized to the pre-bleach average.
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4. Discussion
In this work, we performed a detailed analysis of the role played by the quaternary
structure for the fitness and subcellular localization of a peroxisomal matrix protein in a
live cellular system. We used, as model human AGT, a dimeric enzyme whose deficit is
associated with the rare disease PH1 [25]. AGT folds in the cell cytosol and is then targeted
to peroxisomes by a C-terminal PTS1 KKL sequence [54]. AGT contains one of the weakest
PTS1 sequences known for human peroxisomal proteins, as already reported and confirmed
by our data (Table S3), but it is efficiently imported due to the high protein levels [55,56].
Consequently, any event that may sequester AGT from the cytosolic pool available for
interaction with Pex5 could prevent its proper import. The current model of the AGT
folding pathway postulates the formation of monomeric intermediates that first generate
an apodimer, which subsequently binds PLP and is imported to peroxisomes. Along
this pathway, partially folded states can interact with molecular chaperones [29,31,57].
Dimerization likely plays a crucial role in the folding and correct peroxisomal import of
the protein [30], thus, making AGT an ideal model to investigate the interplay between
folding, dimerization, and import.
Herein, we have tested this interplay by comparing the behavior of the native dimeric
and artificial monomeric forms of AGT in mammalian cells, as well as the influence of
a polymorphism that makes the protein susceptible to mitochondrial mistargeting [27].
Our data demonstrate that interfering with dimerization strongly impacts the intracellular
behavior of AGT in many respects. First, artificial monomeric AGT is more susceptible
to degradation than the corresponding dimer, in line with its reduced conformational
stability. We can hypothesize that proteolytic degradation is triggered by both the exposure
of hydrophobic surfaces at the monomer–monomer interface and the presence of a highly
flexible N-terminal tail, which wraps the neighboring subunit in the dimer but becomes
exposed to cytosolic proteases in the monomer [39,49,58]. Indeed, Western blot data
indicate that monomeric AGT is prone to proteolytic cleavage at the N-terminus. Second,
artificial monomeric AGT tends to aggregate, as indicated by Western blot experiments.
In addition, immunofluorescence microscopy experiments, in both fixed and live cells
expressing MMa, suggest partial protein accumulation in the cytosol. It is known that
purified AGT has a strong tendency to aggregate by processes driven by partial unfolding,
hydrophobic interactions, and/or electrostatic forces [31,50,57]. Although it is difficult to
identify the main driving force for intracellular aggregation, exposed hydrophobic surfaces
of the interface are likely to play a major role.
Notwithstanding the major impact of dimerization on protein folding and stability,
we unexpectedly found that monomeric forms can still be imported into peroxisomes,
although with lower efficiency as a partial cytosolic localization was clearly present. The
latter phenomenon, observed in both fixed and live cells, does not depend on an impaired
interaction with the Pex5p carrier, nor different kinetics of import, as revealed by the
use of the FRAP technique. To the best of our knowledge, this paper reports the first
application of the FRAP technique to measure the import kinetics of a matrix peroxisomal
protein in live cells, with the major advantage over previous work to avoid incorporation
of fluorescent tags that may affect intracellular behavior and interaction with the import
machinery. Rather, AGT was engineered to interact with the FlAsH dye that is suitable for
live cell analyses [59]. Indeed, the FlAsH target sequence was added to an AGT external
loop previously used for imaging studies [52], and we verified that the modification does
not interfere with the molecular properties of each enzymatic form under study, although
it reduces intracellular protein levels. These experiments revealed that the import of AGT
is very rapid and occurs with kinetics in a time scale of seconds. This rate appears to
be higher than that previously reported for other peroxisomal proteins, such as catalase,
dihydroxyacetone synthase, or urate oxidase [16,60–62], and the use of indirect assays or
in vitro transcription/translation systems, rather than a direct fluorescence measure, may
account for some of these discrepancies.
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Notably, FRAP experiments suggest that monomeric and dimeric AGT have similar
import kinetics. It must be pointed out that our approach does not allow a direct visual
discrimination between the two forms. Nevertheless, cross-linking experiments on the
total cell lysate (Figure S3a) clearly indicate that MMa, with or without the FlAsH target
sequence, should be present as monomers. Thus, we can suggest that monomeric and
dimeric AGT could be actually imported as monomers and dimers, respectively. Following
this view, the peroxisomal import machinery does not seem to show a preference based
on the AGT quaternary structure, in line with previous reports [63]. From a structural-
thermodynamic point of view, this agrees with the finding that the principal and ancillary
targeting sequences of AGT are not part of the monomer–monomer interface [54,56], thus,
indicating that there is no obvious competition between Pex5p binding and AGT oligomer-
ization. Previous studies have focused on the equilibrium of the process, i.e., on the ability
of Pex5p to recognize monomeric or oligomerized cargoes, as well as on the role of Pex5p
binding in counteracting oligomerization, and contrasting results have been reported.
On the one hand, some studies have shown that peroxisomes can import oligomerized
proteins, mainly based on the evidence that some matrix proteins are imported as hetero-
oligomers by a piggy-back pathway [18,19]. On the other hand, however, some proteins are
imported as monomers with Pex5p binding blocking oligomerization [12,20,21], and the
idea that the peroxisomal import machinery shows a preference for monomeric substrates
is largely supported in the case of homo-oligomers. Our results support a model in which
the checkpoint for the import of AGT is not the interaction with the carrier, which occurs
with similar kinetics and equilibrium for monomeric and dimeric forms, but rather the
efficiency of cargo folding in the cytosol. Indeed, the population of monomeric folding in-
termediates may undergo distinct events, which include possible degradation, aggregation,
dimerization, and peroxisomal import [57,63]. Under normal physiological conditions, it
is likely that the rate of AGT dimerization far exceeds that of aggregation or degradation
so that the protein is probably imported as a holodimer into peroxisomes. If interference
with dimerization occurs, the population of monomeric intermediates is increased and
becomes available for events other than import, with the final result to reduce the amount
of functional intraperoxisomal AGT. On the contrary, the treatment with molecules that
promote dimerization shifts the balance away from degradation and aggregation in favor
of oligomerization and correct folding. One example is the treatment with PN, which
leads to the intracellular accumulation of PLP. Many studies of our group and others have
highlighted how the coenzyme is able to promote AGT dimerization [39,40,64,65], an effect
explained by the fact that the enzyme active site is made up of residues coming from both
subunits, and thus, coenzyme binding also stabilizes monomer–monomer interactions [32].
Nevertheless, our study suggests that coenzyme administration, in the form of PN, is
able to act on monomeric AGT and induce dimerization. This model also reconciles the
findings that monomeric AGT forms generate aggregates probably stabilized by hydropho-
bic interactions, while truncated AGT that undergoes a normal dimerization generates
intraperoxisomal aggregates stabilized by electrostatic forces [49]. This view is reinforced
by the finding that the import would locally concentrate the protein, a condition that
strongly favors aggregation from dimeric native or native-like species but would prevent
aggregation from monomeric species by stabilizing the dimer [50]. In this scenario, the
minor allele polymorphism makes monomeric AGT more susceptible to degradation and
aggregation. This is probably due to the P11L mutation that increases the flexibility of the
N-terminal arm, which becomes more prone to intracellular cleavage and destabilizes the
dimer [41,45,57].
Overall, our data reveal that folding kinetics of cargo proteins in the cytosol may
play a key role in peroxisomal import of matrix proteins, thus, contributing to the overall
efficiency of the import process. In this regard, it cannot be excluded that peroxisomal
import/cytosolic accumulation could also represent a mechanism to regulate the activity
of enzymes, as previously reported for inducible nitric oxide synthase [66]. It is also worth
speculating that evolutionary divergence in consensus amino acids along mammalian
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speciation could lead to changes in folding/unfolding kinetics in the cytosol, thus, con-
tributing to the differences in intracellular location observed among AGT proteins from
mammalian species [67].
Our results also provide insights into the pathogenesis of PH1, which is considered a
misfolding disease because most pathogenic missense mutations reduce the efficiency of
the AGT folding pathway [68]. We can suggest that mutations increasing the population
of monomeric intermediates likely result in enhanced cytosolic degradation, aggregation,
and eventual mistargeting if associated with the minor allele. Particularly, the structural
and folding perturbations caused by the most common PH1 mutations (such as G170R,
F152I, and I244T) may cause simultaneously aggregation and mistargeting of the en-
zyme [41,69,70], and the preference of a given mutation for one or the other mechanism
may depend on how efficiently the energetic perturbation on the dimeric and monomeric
forms of AGT relevantly translate into the rate-limiting states for each pathogenic mecha-
nism. Interestingly, these mutations are also clinically responsive to PN administration, in
line with our data, which definitely prove that PN is able to rescue for dimerization and sta-
bility impairments. On the other hand, the effects of mutations resulting exclusively in the
formation of intraperoxisomal aggregates, such as the Gly41 variants [58], probably cause
less pronounced effects on dimerization kinetics, but are more related to conformational
changes of the dimeric form, making the protein prone to self-association upon efficient
import into the peroxisomal matrix.
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